BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30334177)

  • 1. Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study.
    Li ZL; Yan WT; Zhang J; Zhao YJ; Lau WY; Mao XH; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Wu H; Li C; Wang MD; Wu MC; Shen F; Yang T
    J Gastrointest Surg; 2019 Feb; 23(2):288-296. PubMed ID: 30334177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
    Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
    Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
    Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
    JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
    Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.
    Rui S; Yan J; Zhang H; Wang Z; Zhou W
    Medicine (Baltimore); 2017 Jul; 96(30):e7608. PubMed ID: 28746212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.
    Lee JI; Kim JK; Chang HY; Lee JW; Kim JM; Chung HJ; Kim YS; Lee KS
    J Gastroenterol Hepatol; 2014 May; 29(5):1019-27. PubMed ID: 24325315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
    Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
    JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
    Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC
    PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.
    Huang S; Xia Y; Lei Z; Zou Q; Li J; Yang T; Wang K; Yan Z; Wan X; Shen F
    J Am Coll Surg; 2017 Mar; 224(3):283-293.e4. PubMed ID: 27923614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
    Li Q; Li H; Qin Y; Wang PP; Hao X
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.
    Zhou YM; Zhang XF; Li B; Sui CJ; Yang JM
    Ann Surg Oncol; 2014 Jul; 21(7):2406-12. PubMed ID: 24577811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.